In this episode of the Active Ingredientspodcast, host Thomas Dove interviews Derek McCaig,Commercial Strategist and Transformation Leader.
Derek brings decades of experience launching life-changing medicines across some of healthcare's most complex corners, from the first wave of HIV treatments in the 1990s to rare diseases and gene therapy today. His career spans leading organizations at Big Pharma, scaling biotech startups, and bringing commercial clarity to breakthroughs.
In this conversation, Derek shares insights on leading at different altitudes, balancing compassion with pragmatism, and why the most meaningful wins often come from the people and lessons rather than the product itself.
Key Takeaways
- Discover how trust, empowerment, and adaptability form the foundation of exceptional leadership, fostering environments where teams take calculated risks and deliver outstanding performance in life sciences organizations.
- Discover practical approaches for leading through uncertainty in emerging therapeutic areas, such as gene therapy, where answers aren't predetermined, and teams must collaborate to explore new solutions together.
- Understand the art of intellectual leadership when navigating between commercial realities and scientific passion, helping R&D teams broaden perspectives whilst respecting their life's work.
- Explore how to scale leadership across different organizational sizes, from managing 200-person sales forces to intimate rare disease teams, whilst maintaining core empowerment principles.
- Take away Derek's framework for building a high-performing team that incorporates diverse perspectives, robust debate, consensus-driven decision-making, and an unwavering focus on patient outcomes.
- Gain insights into leading during setbacks and failures, understanding how commercial leaders can maintain team motivation when clinical trials fail but still contribute valuable data to the industry.
- Apply lessons from Derek's experience transitioning between Big Pharma and biotech, learning when to trust teams versus when to roll up sleeves in smaller, agile environments.
- Uncover strategies for maintaining purpose-driven leadership in rare diseases and gene therapy, where individual patient stories provide powerful motivation for commercial teams.
Snippets
- I think it's really important to build trust with your team within the organization. I think a big part of that is also integrity."
- "When people don't feel that trust and don't feel that integrity, they're just a little more reticent."
- "There's nothing better than working on genuine innovation. Where you are helping the community...to really solve those problems."
- "The wisdom is in a team, you know, it's not in me.
- "I do believe that everybody comes to work in this industry with the ultimate aim of getting medicines that really change diseases and change people's lives."
Timestamps & Topics
- 00:08:00 -- Introduction: Derek McCaig's journey from HIV treatments to gene therapy
- 00:09:30 -- The Three Active Ingredients: Trust, empowerment and adaptability in leadership
- 00:12:30 -- Early Career Foundation: From pharmacy school to first leadership role at age 21
- 00:17:00 -- Leading Through Innovation: HIV treatments and working at the cutting edge
- 00:28:00 -- Scaling Leadership: Managing large sales forces versus intimate rare disease teams
- 00:35:00 -- Intellectual Leadership: Bridging commercial realities with scientific passion
00:47:00 -- Building High-Performance Teams: Risk-taking, debate and consensus in biotech
Resources
Don’t Miss an Episode
Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on Apple Podcasts, Spotify, and other leading podcast platforms.
Feedback
Share it with your friends, family or your peers!
